Powerful Medical cardio (PMcardio) has announced that its Queen of Hearts artificial intelligence (AI) model used within the PMcardio platform has outperformed physicians when diagnosing heart attacks.
Over 523 million people are affected by cardiovascular disease around the world and 19 million deaths were documented in 2020, according to the Centers for Disease Control and Prevention (CDC).
According to GlobalData analysis, AI algorithms are becoming more prevalent in cardiology, facilitating digestion of cardiac data to identify patterns and abnormalities and detect subtle indications of cardiac conditions that may be missed by human interpretation alone.
The platform from PMcardio utilises information from its database of 500,000 patients to detect heart attacks. It also uses its AI model to detect heart attacks which they claim can identify the problem three hours before a human clinician.
Dr. Robert Herman, Chief Medical Officer at Powerful Medical said: “Alarmingly, one in four men and one in three women die within five years of a heart attack, often due to the irreversible damage to the heart muscle caused by delayed treatment. This is particularly concerning for women, who tend to have less obvious heart attack symptoms than men, making accurate and timely diagnosis even more critical,”
The clinical assistant has been used in clinical trials which included over 20,000 patients and demonstrated the effectiveness of the AI model. It is also being used over 60 pilot programs around the world with institutions like Minneapolis Heart Institute, Christ Hospital, Prairie Hospital, and Cardiovascular Center Aalst in Belgium participating.
Martin Herman, CEO of Powerful Medical said: “Each year, around 3 million patients are admitted to emergency departments with chest pain in the United States, and the total economic cost of heart attacks exceeds $150 billion annually. Through our clinical trials, we have demonstrated that the Queen of Hearts can significantly reduce these costs by enabling accurate diagnosis and prioritization of patients.”
In March 2023, PMcardio launched in the UK supplying its AI clinical assistant to more than 7 million individuals who are at risk of heart attack.
